Add BrightSurf on Google Email

New blood test determines whether you have or are likely to get cancer

Researchers developed a new blood test called the lymphocyte genome sensitivity (LGS) test, which can detect some cancers earlier than ever before. The test analyzes white blood cells exposed to UVA light and measures their DNA damage, allowing for early cancer detection and identifying those at risk of developing cancer.

The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe

A large population-based study of European adults with blood cancers found that regional differences in treatment and care quality contribute to varying survival rates. The study analyzed data from 30 cancer registries covering all patients diagnosed in 20 European countries between 1997 and 2008.

SourceThe Lancet·JournalThe Lancet Oncology·DateJul 13, 2014

Virus-derived particles target blood cancer

Researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice. These non-replicating particles, derived from rhabdovirus, work by direct cytolysis and induction of antitumor immunity, showing promise as a new therapy for leukemia.

SourceThe Ottawa Hospital·JournalBlood Cancer Journal·DateAug 13, 2013